Back to search
FDAFDA · Food and drugs·Recall number D-0632-2020

RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32

Published January 8, 2020 · Recall initiated: December 13, 2019

Summary

FDA records drug Class II recall D-0632-2020, published January 8, 2020 and initiated December 13, 2019. Recalling firm: Granules India Limited; Status: Ongoing; Reported quantity: 23,090,000 tablets; Lot: 7730001A, 7730002A, 7730003A, 7730004A, 7730005A, 7730006A, 7730007A, 7730008A, 7730009A, 7730010A, 7730011A and 7730012A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

What to do

Voluntary: Firm initiated · Letter

Get an email if RANITIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
RANITIDINE
Manufacturer
Granules India Limited
Distributor
OR, NY, NJ
Lot
7730001A, 7730002A, 7730003A, 7730004A, 7730005A, 7730006A, 7730007A, 7730008A, 7730009A, 7730010A, 7730011A and 7730012A
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32 recalled?

Yes. FDA published recall D-0632-2020 on January 8, 2020. Reported hazard: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: RANITIDINE.